Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vanessa Vergara Bravo
Observed name:
V Vergara Bravo
Institution:
IVIRMA Global
Observed institution:
IVIRMA Global
ORCID:
0000-0001-5140-3625
Observed ORCID:
0000-0001-5140-3625
OpenAlex ID:
A5113277442
Preimplantation genetic testing for aneuploidy mosaicism reporting lacks clinical predictive value for live birth in a multisite, double-blinded study with independent validation
2025
·
Pavan Gill
, Xin Tao
, et al.
·
American Journal of Obstetrics and Gynecology
·
11
PDF
Cost effectiveness of routine utilization of atypically-pronucleated zygotes in in vitro fertilization cycles with preimplantation genetic testing
2026
·
Antonio Capalbo
, Francesca Mulas
, et al.
·
Fertility and Sterility
Mapping performance in 114,237 IVF cycles with donor oocytes reveals reproducible inefficiencies and distinct endophenotypes
2025
·
Christian Simon Ottolini
, Francesca Mulas
, et al.
·
medRxiv
PDF
O-071 Stringent statistical analysis of 108,684 oocyte donation cycles identifies 2.6% of donors with specific oocyte/embryo developmental arrest phenotypes for genome association studies
2024
·
C Ottolini
, F Mulas
, et al.
·
Human Reproduction
PDF
Pituitary suppression protocol does affect clinical outcomes in egg donation cycles
2017
·
Vanessa Vergara Bravo
Show more works
View as search
Works count:
5
Citation count:
11
H-index:
1
I10-index:
1
Year
Topic
Type
